Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History

  • Olinto Linares-Perdomo1,2
  • Damon Klebe1,2
  • Fumiko Chino3
  • Bismarck C. Odei2
  1. 1Huntsman Cancer Institute, University of Utah, Salt Lake City
  2. 2Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah Health, Salt Lake City
  3. 3Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston
Open at sourceDOICite

Abstract

This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.

Related

  1. GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults
    Arthur Heng-Cheng Hsu, Pedro Tomas Ramirez, Y.-H. Chang +6
    Annals of OncologyPeer-reviewedLicence not statedFull text12 citedEndocrinology & metabolismOpenAlex
  2. GLP-1 Receptor Agonist Initiation Is Associated With Excess Skeletal Muscle Loss in Adults With Diabetes: A Prospective Population-Based MRI Study
    E. Stambollxhiu, J. Luebberstedt, M. Kumpf +9
    medRxivPreprintCC BY-NC-NDFull textEndocrinology & metabolismmedRxiv
  3. Association of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.
    Ching-Chung Hsiao, Ming-Hsien Tsai, Jian-Yu Jhu +4
    International journal of medical sciencesPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  4. GLP-1 receptor agonist initiation and newly recorded ankylosing spondylitis diagnoses in type 2 diabetes: a target trial emulation
    Yu-Chen Lu, Tzu-Hao Li, Ya-Fang Liu +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
  5. Patterns of GLP-1 Receptor Agonist Initiation Compared With Other Glucose-Lowering and Anti-Obesity Therapies Among Older Adults
    J. D. Brooks, M. A. Donahue, A. ElHassan +6
    medRxivPreprintAll rights reservedFull textEndocrinology & metabolismmedRxiv

Cite

BibTeXRIS
BibTeX
@article{linaresperdomo2026glp1,
  title = {{GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History}},
  author = {Olinto Linares-Perdomo and Damon Klebe and Fumiko Chino and Bismarck C. Odei},
  journal = {JAMA Network Open},
  year = {2026},
  month = oct,
  doi = {10.1001/jamanetworkopen.2026.37813},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854936},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History
AU  - Olinto Linares-Perdomo
AU  - Damon Klebe
AU  - Fumiko Chino
AU  - Bismarck C. Odei
PY  - 2026
DA  - 2026/10/07
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.37813
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854936
AB  - This cross-sectional study examines how use of glucagon-like peptide-1 (GLP-1) receptor agonists varies among US adults with diabetes with or without a history of cancer.
SN  - 2574-3805
ER  -